The clinical characteristics of COVID-19 coagulopathy are distinct from DIC because of moderate decrease in platelet counts, mild prolongation of prothrombin time, and extremely high fibrinogen levels despite systemic thrombin and plasmin generation (50, 112, 113). Here, F2 is linked to blood coagulation disease.